01-03-2024 | Basiliximab | Case report
Antithymocyte-globulin/Basiliximab/Valganciclovir
Cytomegalovirus viraemia and lack of efficacy
Published in: Reactions Weekly | Issue 1/2024
Login to get accessExcerpt
Author Information-
* death
-
* life-threatening
-
* hospitalisation
-
* disability
-
* congenital anomaly
-
* other medically important event